Related Experiment Video
Updated: Feb 28, 2026

A High-Throughput Platform for Culture and 3D Imaging of Organoids
Published on: October 14, 2022
High-Throughput 3D Tumor Culture in a Recyclable Microfluidic Platform
1College of Science, Northwest A&F University, No. 22 Xinong Road, Yangling, Shaanxi, 712100, China. liuwenming0229@nwsuaf.edu.cn.
This study introduces a reusable microfluidic platform for dynamic, high-throughput 3D tumor culture. This method enables efficient cell manipulation for biomimetic models and disease studies.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Microfluidics
Background:
- Three-dimensional (3D) tumor cultures are crucial for biomimetic models and studying disease.
- Current methods lack dynamic control and high-throughput capabilities for micro-scale cell manipulation.
Purpose of the Study:
- To describe a novel method for dynamic 3D tumor manipulation and culture.
- To develop a reusable microfluidic platform for efficient, high-throughput tumor studies.
Main Methods:
- Utilized pneumatic microstructure-based microfluidics for dynamic control.
- Developed a miniaturized, reusable platform for 3D tumor culture.
- Enabled high-throughput cell-based manipulation at the micro-scale.
Main Results:
- Demonstrated a dynamically controlled method for 3D tumor manipulation.
- Achieved high-throughput production of 3D tumor cultures.
- Platform is reusable, enhancing convenience for researchers.
Conclusions:
- The described method offers a dynamic and efficient approach to 3D tumor culture.
- This technology has potential applications in tissue engineering, tumor biology, and clinical medicine.
- The reusable microfluidic platform supports high-throughput research.
More Related Videos
12:12Enhanced Viability for Ex vivo 3D Hydrogel Cultures of Patient-Derived Xenografts in a Perfused Microfluidic Platform
Published on: December 5, 2020
10:38Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
Published on: December 16, 2022